CHASE CROSS MEDICAL CENTRE — All Prescriptions & Medications
Practice Code: F82630 | ROMFORD, RM5 3PJ
Over the last 12 months, CHASE CROSS MEDICAL CENTRE prescribed 118,649 items across 508 different medications at a total cost of £1,210,287 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Sodium bicarbonate | 10 | 3,000 | £561 | +17.3% ▲ |
| Labetalol hydrochloride | 10 | 784 | £77 | -56.0% ▼ |
| Colestyramine | 10 | 810 | £201 | -65.3% ▼ |
| Levocetirizine | 10 | 372 | £47 | -35.8% ▼ |
| Chloral hydrate | 10 | 1,500 | £2.4K | -1.2% vs avg |
| Levomepromazine maleate | 10 | 154 | £219 | +8.9% ▲ |
| Domperidone | 10 | 1,009 | £21 | -72.0% ▼ |
| Dihydrocodeine tartrate | 10 | 766 | £47 | -94.9% ▼ |
| Rimegepant | 10 | 212 | £2.7K | +1.9% vs avg |
| Hydrocortisone | 10 | 600 | £33 | -88.2% ▼ |
| Tamsulosin and dutasteride hydrochloride | 10 | 480 | £121 | -71.4% ▼ |
| Calcium folinate | 10 | 280 | £1.1K | +27.2% ▲ |
| Sodium bicarbonate | 10 | 40 | £1.1K | +103.6% ▲ |
| Zinc sulfate monohydrate | 10 | 930 | £174 | +12.9% ▲ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 10 | 300 | £21 | -33.4% ▼ |
| Clindamycin phosphate | 10 | 630 | £106 | -39.2% ▼ |
| Other individually formulated bought in preparations | 10 | 330 | £190 | -69.4% ▼ |
| 10 | 300 | £181 | -73.1% ▼ | |
| 10 | 23 | £263 | -37.5% ▼ | |
| 10 | 259 | £107 | -75.4% ▼ | |
| 10 | 275 | £66 | -79.8% ▼ | |
| Verapamil hydrochloride | 11 | 1,260 | £25 | -87.9% ▼ |
| Midodrine hydrochloride | 11 | 924 | £248 | -77.4% ▼ |
| Testosterone enantate | 11 | 11 | £351 | +54.0% ▲ |
| Exemestane | 11 | 538 | £107 | -66.1% ▼ |
| Tizanidine hydrochloride | 11 | 924 | £162 | -58.5% ▼ |
| Travoprost | 11 | 55 | £34 | -76.7% ▼ |
| Apraclonidine | 11 | 184 | £716 | -12.7% ▼ |
| Other preparations | 11 | 930 | £172 | +13.7% ▲ |
| 11 | 65 | £174 | -54.6% ▼ | |
| 11 | 21 | £993 | +26.3% ▲ | |
| 11 | 2,750 | £388 | -71.7% ▼ | |
| 11 | 550 | £94 | -50.8% ▼ | |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 12 | 672 | £317 | -26.6% ▼ |
| Perindopril arginine | 12 | 510 | £102 | +1.5% vs avg |
| Olmesartan medoxomil | 12 | 336 | £21 | -82.6% ▼ |
| Olmesartan medoxomil/hydrochlorothiazide | 12 | 672 | £356 | +21.0% ▲ |
| Imipramine hydrochloride | 12 | 2,016 | £66 | -52.9% ▼ |
| Phenytoin | 12 | 26.9K | £219 | +9.3% ▲ |
| Opicapone | 12 | 720 | £1.4K | -37.3% ▼ |
| Glimepiride | 12 | 504 | £15 | -87.0% ▼ |
| Cabergoline | 12 | 96 | £171 | -22.6% ▼ |
| Pdr 3.7 kcal/g energy and higher protein fortifier (0913141) | 12 | 6,075 | £341 | +59.8% ▲ |
| Meloxicam | 12 | 360 | £10 | -81.9% ▼ |
| Dantrolene sodium | 12 | 1,084 | £445 | -33.5% ▼ |
| Acetylcysteine | 12 | 120 | £945 | +18.4% ▲ |
| Benzoyl peroxide | 12 | 360 | £62 | -14.8% ▼ |
| 12 | 1,840 | £680 | -18.3% ▼ | |
| 12 | 510 | £829 | +50.2% ▲ | |
| Valsartan | 13 | 784 | £202 | -77.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.